Emergent Biosolutions Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results and Issued FY24 Revenue Guidance Below Estimates
Emergent Biosolutions的股價走低,此前該公司公佈的第四季度財務業績低於預期,併發布的24財年收入指引低於預期
Emergent Biosolutions Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results and Issued FY24 Revenue Guidance Below Estimates
Emergent Biosolutions的股價走低,此前該公司公佈的第四季度財務業績低於預期,併發布的24財年收入指引低於預期
使用瀏覽器的分享功能,分享給你的好友吧